Xiaohan Hou

发表

Potent Hydrazide-Based HDAC Inhibitors with a Superior Pharmacokinetic Profile for Efficient Treatment of Acute Myeloid Leukemia In Vivo.

Min Li, C. Chou, Xiaoyang Li, 2021, Journal of medicinal chemistry.

Coupling LaNiO3 Nanorods with FeOOH Nanosheets for Oxygen Evolution Reaction

Fengbao Zhang, Xiaobin Fan, Yang Li, 2022, Catalysts.

First-in-Class Hydrazide-Based HDAC6 Selective Inhibitor with Potent Oral Anti-Inflammatory Activity by Attenuating NLRP3 Inflammasome Activation.

C. Chou, Xiaoyang Li, Kairui Yue, 2022, Journal of medicinal chemistry.

Design, synthesis and biological evaluation of hybrid of ubenimex-fluorouracil for hepatocellular carcinoma therapy.

Xuejian Wang, Jian Zhang, Wenfang Xu, 2021, Bioorganic chemistry.

Formal [4+1] Cyclization of ortho ‐ or para ‐Quinone Methides with 3‐Chlorooxindoles: Synthesis of 3,2′‐Tetrahydrofuryl Spirooxindoles

Xiaoyang Li, Xiaochen Tian, Yang Wang, 2021, Asian Journal of Organic Chemistry.

Catalyst-free and atom-economical 1,3-dipolar cycloaddition of C,N-cyclic azomethine imines: Facile synthesis of isoquinoline-fused spirocycles

Tao Liu, Yang Wang, Xiaohan Hou, 2021, Green Synthesis and Catalysis.

Synthesis and bioactivity evaluation of ferrocene-based hydroxamic acids as selective histone deacetylase 6 inhibitors.

Ximing Xu, Xiaoyang Li, Jing Wang, 2022, European journal of medicinal chemistry.

A GLUT1 inhibitor-based fluorogenic probe for Warburg effect-targeted drug screening and diagnostic imaging of hyperglycolytic cancers.

Weijie Song, Xinyu Wang, Heming Zhang, 2021, Analytica chimica acta.

Discovery of benzamide-based PI3K/HDAC dual inhibitors with marked pro-apoptosis activity in lymphoma cells.

Xiaohan Hou, Xiaoyang Li, Jingjing Deng, 2023, European journal of medicinal chemistry.